Log in to save to my catalogue

Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillati...

Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43e81d6124704618a11c2c5a40efbc2c

Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study

About this item

Full title

Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2023-07, Vol.22 (1), p.175-175, Article 175

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

This ANAFIE Registry sub-analysis investigated 2-year outcomes and oral anticoagulant (OAC) use stratified by glycated hemoglobin (HbA1c) levels among Japanese patients aged ≥ 75 years with non-valvular atrial fibrillation (NVAF) with and without clinical diagnosis of diabetes mellitus (DM).
The ANAFIE Registry was a large-scale multicenter, obs...

Alternative Titles

Full title

Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_43e81d6124704618a11c2c5a40efbc2c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43e81d6124704618a11c2c5a40efbc2c

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-023-01915-3

How to access this item